Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
A New Era for Treatment of Advanced Head and Neck Cancers
EP. 1: Underlying Biology of HPV-Positive and -Negative HNSCC
November 7th 2016
EP. 2: Prognostic Factors for HNSCC
November 7th 2016
EP. 3: HPV Testing in HNSCC
November 7th 2016
EP. 4: Factors Influencing Treatment Decisions for HNSCC
November 7th 2016
EP. 5: Locoregionally Advanced HNSCC
November 7th 2016
EP. 6: Goals of Therapy for HNSCC
November 7th 2016
EP. 7: Long-Term Toxicity in HNSCC
November 7th 2016
EP. 8: Surgery and Radiotherapy for HNSCC
November 7th 2016
EP. 9: Appropriate Use of Chemotherapy in HNSCC
November 7th 2016
EP. 10: Debates Surrounding Induction Chemotherapy in HNSCC
November 7th 2016
EP. 11: Unmet Needs in Recurrent HNSCC
November 7th 2016
EP. 12: Enter PD-1 Inhibitors; A New Paradigm for HNSCC
November 7th 2016
EP. 13: Pembrolizumab and Nivolumab in Recurrent HNSCC
November 7th 2016
EP. 14: Patient Selection for Pembrolizumab in HNSCC
November 7th 2016
EP. 15: Emerging Concepts for Immunotherapy in HNSCC
November 7th 2016
EP. 16: Immune-Based Approaches in the Curative Setting of HNSCC
November 7th 2016